Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

RAPT Therapeutics Q4 EPS $(0.80) Beats $(0.86) Estimate, Cash Balance of $158.9M as of December 31, 2023

Author: Benzinga Newsdesk | March 07, 2024 09:06am
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0.86) by 6.98 percent. This is a 25 percent decrease over losses of $(0.64) per share from the same period last year.

Posted In: RAPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist